Steven Cohen's RLAY Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 14.77 M shares of Relay Therapeutics, Inc. (RLAY) worth $77.12 M, representing 0.13% of the portfolio. First purchased in 2023-Q2, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in RLAY, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 9.23 M shares. Largest reduction occurred in Q2 2024, reducing 952,019 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Relay Therapeutics (RLAY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Relay Therapeutics (RLAY) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2023 | +276,540 | New Buy | 276,540 | $12.56 |
| Q3 2023 | -256,325 | Reduce 92.69% | 20,215 | $8.41 |
| Q4 2023 | -20,215 | Sold Out | 0 | $0.00 |
| Q1 2024 | +952,019 | New Buy | 952,019 | $8.30 |
| Q2 2024 | -952,019 | Sold Out | 0 | $0.00 |
| Q3 2024 | +1.35 M | New Buy | 1.35 M | $7.08 |
| Q4 2024 | +243,353 | Add 18.03% | 1.59 M | $4.12 |
| Q1 2025 | +9.23 M | Add 579.77% | 10.83 M | $2.62 |
| Q2 2025 | +2.62 M | Add 24.19% | 13.45 M | $3.46 |
| Q3 2025 | +1.33 M | Add 9.88% | 14.77 M | $5.22 |
Steven Cohen's Relay Therapeutics Investment FAQs
Steven Cohen first purchased Relay Therapeutics, Inc. (RLAY) in Q2 2023, acquiring 276,540 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Relay Therapeutics, Inc. (RLAY) for 10 quarters since Q2 2023.
Steven Cohen's largest addition to Relay Therapeutics, Inc. (RLAY) was in Q1 2025, adding 10,827,067 shares worth $28.37 M.
According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 14,773,676 shares of Relay Therapeutics, Inc. (RLAY), valued at approximately $77.12 M.
As of the Q3 2025 filing, Relay Therapeutics, Inc. (RLAY) represents approximately 0.13% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Relay Therapeutics, Inc. (RLAY) was 14,773,676 shares, as reported at the end of Q3 2025.